29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070728/0/en/Artios-Pharma-Reports-Differentiated-Clinical-Activity-in-STELLA-Phase-1-2a-Study-for-Lead-Program-ART0380-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2025.html
19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2932080/0/en/Processa-Pharmaceuticals-Announces-Positive-Preclinical-Data-for-NGC-Iri.html
https://investors.merrimack.com/news-releases/news-release-details/merrimack-reports-ipsen-announcement-approval-us-fda-onivyder
14 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/14/2688483/0/en/Correction-Ipsen-announces-U-S-FDA-submission-acceptance-of-its-supplemental-New-Drug-Application-for-Onivyde-regimen-in-first-line-metastatic-pancreatic-ductal-adenocarcinoma.html
20 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/edison-oncology-announces-presentation-of-two-scientific-posters-at-aacr-annual-meeting-301803139.html
21 Jan 2023
// Zoey Becker FIERCE PHARMA
https://www.fiercepharma.com/pharma/ipsens-onivyde-proves-its-worth-previously-untreated-specific-pancreatic-cancer